Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study

Other authors

[Martínez E] Intensive Care Unit, Hospital General de Granollers, Granollers, Spain. Intensive Care Unit, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain. University of Barcelona, Barcelona, Spain. [Foncillas A] Infectious Diseases Department, Hospital Clínic, Barcelona, Spain. [Téllez A, Fernández S] Medical Intensive Care Unit, Hospital Clínic, Barcelona, Spain. [Martínez-Nadal G] Medical Intensive Care Unit, Hospital Clínic, Barcelona, Spain. Emergency Department, Hospital Clínic, Barcelona, Spain. [Rico V] Infectious Diseases Department, Hospital Clínic, Barcelona, Spain. Medical Intensive Care Unit, Hospital Clínic, Barcelona, Spain. Hospital at Home, Hospital Clínic, Barcelona, Spain

Hospital General de Granollers

Publication date

2025-02-17T07:43:27Z

2025-02-17T07:43:27Z

2024-10-11



Abstract

Acquired immunodeficiency syndrome (AIDS); Antiretroviral therapy; Intensive care unit


Síndrome de inmunodeficiencia adquirida (SIDA); Terapia antirretroviral; Unidad de cuidados intensivos


Síndrome d'immunodeficiència adquirida (SIDA); Teràpia antiretroviral; Unitat de cures intensives


Purposes: Since 2016, the World Health Organization has recommended universal antiretroviral therapy (ART) for all people living with Human Immunodeficiency Virus (PLHIV). This recommendation may have influenced the characteristics and outcomes of PLHIV admitted to the Intensive Care Unit (ICU). This study aims to identify changes in the epidemiological and clinical characteristics of PLHIV admitted to the ICU, and their short- and medium-term outcomes before and after the implementation of universal ART (periods 2006-2015 and 2016-2019). Methods: This retrospective, observational, single-center study included all adult PLHIV admitted to the ICU of a University Hospital in Barcelona from 2006 to 2019. Results: The study included 502 admissions involving 428 patients, predominantly men (75%) with a median (P25-P75) age of 47.5 years (39.7-53.9). Ninety-one percent were diagnosed with HIV before admission, with 82% under ART and 60% admitted from the emergency department. In 2016-2019, there were more patients on ART pre-admission, reduced needs for invasive mechanical ventilation (IMV) and fewer in-ICU complications. ICU mortality was also lower (14% vs 7%). Predictors of in-ICU mortality included acquired immunodeficiency syndrome defining event (ADE)-related admissions, ICU complications, higher SOFA scores, IMV and renal replacement therapy (RRT) requirement. ART use during ICU admission was protective. Higher SOFA scores, admission from hospital wards, and more comorbidities predicted one-year mortality. Conclusions: The in-ICU mortality of critically ill PLHIV has decreased in recent years, likely due to changes in patient characteristics. Pre- and ICU admission features remain the primary predictors of short- and medium-term outcomes

Document Type

Article


Accepted version

Language

English

Publisher

Springer

Related items

Infection;

https://doi.org/10.1007/s15010-024-02402-x

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)